Comparable Rates of Severe Hypoglycemia in People with Type 2 Diabetes (T2DM) at High Risk of Hypoglycemia Switching to either Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—The Lightning Real-World Predictive Modeling Study

LUIGI MENEGHINI; RONAN ROUSSEL; FANG L. ZHOU; ZSOLT BOSNYAK; JUKKA WESTERBACKA; RACHELE BERRIA; JAVIER JIMENEZ; BJORN ELIASSON; IRENE HRAMIAK; TIMOTHY S. BAILEY

doi:10.2337/db18-97-lb

Comparable Rates of Severe Hypoglycemia in People with Type 2 Diabetes (T2DM) at High Risk of Hypoglycemia Switching to either Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—The Lightning Real-World Predictive Modeling Study

Diabetes ◽

10.2337/db18-97-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 97-LB ◽

Cited By ~ 2

Author(s):

LUIGI MENEGHINI ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

JUKKA WESTERBACKA ◽

...

Keyword(s):

Type 2 Diabetes ◽

High Risk ◽

Insulin Glargine ◽

Predictive Modeling ◽

Real World ◽

Severe Hypoglycemia ◽

Insulin Degludec ◽

Modeling Study

Download Full-text

Similar or Lower Severe Hypoglycemia Rates with Insulin Glargine 300 U/mL (Gla-300) vs. Glargine 100 U/mL (Gla-100), Detemir (IDet), and Insulin Degludec (IDeg) in 112,626 People with Type 2 Diabetes Mellitus (T2DM)—Predictive Modeling Using Real-World Data—Lightning

Diabetes ◽

10.2337/db18-2289-pub ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 2289-PUB

Author(s):

JEREMY PETTUS ◽

TIMOTHY S. BAILEY ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

JUKKA WESTERBACKA ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Predictive Modeling ◽

Real World ◽

Severe Hypoglycemia ◽

Insulin Degludec ◽

Real World Data

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Clinical Research of Insulin Glargine U300 basal‐bolus therapy and Insulin Degludec/Aspart Co‐Formulation in Type 2 Diabetes Mellitus: A Real World Experience (CRIGDA Study)

International Journal of Clinical Practice ◽

10.1111/ijcp.14377 ◽

2021 ◽

Author(s):

Savas Volkan Kisioglu ◽

Ahmet Suat Demir ◽

Damla Tufekci ◽

Yasemin Emur Gunay ◽

Hulya Coskun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Research ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec ◽

Basal Bolus

Download Full-text

Review for "Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: DELIVER Naïve D real‐world study"

10.1111/dom.13793/v1/review3 ◽

2019 ◽

Author(s):

Fernando Gomez-Peralta

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec

Download Full-text

Clinical outcomes in high‐hypoglycaemia‐risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first‐generation basal insulin analogue in the United States : Results from the DELIVER High Risk real‐world study

Endocrinology Diabetes & Metabolism ◽

10.1002/edm2.306 ◽

2021 ◽

Author(s):

Sean D. Sullivan ◽

Nick Freemantle ◽

Rishab A. Gupta ◽

Jasmanda Wu ◽

Charlie J. Nicholls ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

High Risk ◽

Insulin Glargine ◽

Real World ◽

First Generation ◽

Insulin Analogue ◽

The United States ◽

Risk Patients

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

Diabetes ◽

10.2337/db18-1056-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1056-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec

Download Full-text

Review for "Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: DELIVER Naïve D real‐world study"

10.1111/dom.13793/v2/review1 ◽

2019 ◽

Author(s):

Fernando Gomez-Peralta

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec

Download Full-text

Review for "Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: DELIVER Naïve D real‐world study"

10.1111/dom.13793/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec

Download Full-text

Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13793 ◽

2019 ◽

Vol 21 (9) ◽

pp. 2123-2132 ◽

Cited By ~ 9

Author(s):

Sean D. Sullivan ◽

Charlie J. Nicholls ◽

Rishab A. Gupta ◽

Arjun A. Menon ◽

Jasmanda Wu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec

Download Full-text

Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Therapeutic Innovation & Regulatory Science ◽

10.1177/2168479018776943 ◽

2019 ◽

Vol 53 (2) ◽

pp. 279-286

Author(s):

Hanne Theilgaard ◽

◽

Inger Mollerup ◽

Ida Carøe Helmark ◽

Lars Endahl ◽

...

Keyword(s):

Type 2 Diabetes ◽

High Risk ◽

Insulin Glargine ◽

Interim Analysis ◽

Cardiovascular Events ◽

Cardiovascular Outcomes ◽

Insulin Degludec ◽

Cardiovascular Safety

Download Full-text